VTA 120
Alternative Names: VTA-120Latest Information Update: 10 Oct 2023
At a glance
- Originator Vita Therapeutics
- Class Gene therapies; Induced pluripotent stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Facioscapulohumeral muscular dystrophy